LRP-2 (Megalin)
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREE[{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/etzm8qpg0cej7tr7quxd.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5c8/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c8/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/cglxiqygjaki6wpmksxd.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5c7/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c7/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/hbvwlx8wvpvczpjdvpkl.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5c6/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c6/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/zdq1jhiiatpxaisjt3lw.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5c5/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c5/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/omubtzdcsb48t4zmrnor.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5c4/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c4/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/jxect3zdreswm9xsk18n.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5c3/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c3/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/etopmxvfgbondrr3m348.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5c2/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c2/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/beneembqqhpeilpdbbnb.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5c1/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c1/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/z4xrlsconqkxukizkb8l.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5c0/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5c0/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/vlmzolrddzaepagpuyay.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5bf/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5bf/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/supmcepqyvrdaukuupy9.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5be/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5be/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/hvlv7ksxygn5dhsar44x.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5bd/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5bd/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/hi4hlyuap0wnkhrjcimo.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5bc/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5bc/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/lcevrrsnnh6filh9fe5z.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5bb/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5bb/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/nrnbm9aa5fkdszulyqzb.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5ba/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ba/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/nrkpn4qchyu47bvj6bmr.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b9/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b9/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/dlb8gmonrteuufj1odbp.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b8/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b8/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/fvaw5xta0mq6cwrnvnga.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b7/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b7/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/b1olux3eb9o4vppz2yee.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b6/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b6/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/hrgmmpb4kkf58ed8vb1r.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b5/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b5/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/iu5zlbmwv8jf1l7otvf4.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b4/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b4/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/bnjqqzxhxpbqrfeqyoj6.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b3/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b3/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/oksi797xer7nqrtdzkfq.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b2/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b2/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/blaoyzwa45gpcd5wkxbi.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b1/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b1/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/t6vvsh0bn9avjv1xsvlg.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5b0/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5b0/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/itttkzo2bdhrgr3hh8rg.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5af/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5af/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/zxjjuqucilzvurkta4ds.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5ae/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ae/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/hxzc8mtkohh06crr5gch.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5ad/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ad/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/e8dfz4x7dh5erqys7zlm.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5ac/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ac/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/dtekigkl1wsv1vwwlqha.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5ab/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5ab/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/opmrvavase335hoegqrd.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5aa/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5aa/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/a4ndrjlv5lyvlzh5owxq.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5a9/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a9/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/odvqczjdbn8x55orpwdv.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5a8/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a8/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/rb5flbcnrbvjexaav545.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5a7/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a7/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/jtiulyiskhdhevnrcwka.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5a6/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a6/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/uyrpr3sxvjei27fbynun.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5a5/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a5/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/ttciuz1r3aoyvfurcw91.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5a4/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a4/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/qgrbxfbcqriu9g68s1ba.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5a3/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a3/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/yuisqdgzbdrjvznpyvu4.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5a2/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a2/megalin.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1606250319/ltbv21lmqnzuhjg6nkpe.svg#/keystone/api/icons/5fbd6f5503051c0027d1f5a1/megalin.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5fbd6f5503051c0027d1f5a1/megalin.png"}]
Keywords
megalin,LRP2,low density lipoprotein-related protein 2,EGF type,complement type,YWTD,NPXY,gp330,plasma membrane,endocytosis,endothelial,cubilin,thyroid,LRP2,megalin